Perigon Wealth Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $557K | Buy |
6,720
+1,910
| +40% | +$158K | 0.01% | 639 |
|
|
2025
Q1 | $390K | Buy |
4,810
+300
| +7% | +$24.3K | 0.01% | 712 |
|
|
2024
Q4 | $396K | Buy |
4,510
+860
| +24% | +$75.6K | 0.01% | 713 |
|
|
2024
Q3 | $361K | Buy |
3,650
+400
| +12% | +$39.5K | 0.01% | 716 |
|
|
2024
Q2 | $301K | Buy |
3,250
+1,056
| +48% | +$97.9K | 0.01% | 687 |
|
|
2024
Q1 | $208K | Sell |
2,194
-3,375
| -61% | -$320K | 0.01% | 798 |
|
|
2023
Q4 | $497K | Sell |
5,569
-650
| -10% | -$58K | 0.02% | 500 |
|
|
2023
Q3 | $454K | Buy |
6,219
+1,521
| +32% | +$111K | 0.02% | 466 |
|
|
2023
Q2 | $391K | Buy |
4,698
+40
| +0.9% | +$3.33K | 0.02% | 523 |
|
|
2023
Q1 | $355K | Buy |
4,658
+930
| +25% | +$70.9K | 0.02% | 482 |
|
|
2022
Q4 | $309K | Buy |
+3,728
| New | +$309K | 0.02% | 520 |
|
|
2021
Q1 | – | Sell |
-804
| Closed | -$113K | – | 1034 |
|
|
2020
Q4 | $113K | Buy |
+804
| New | +$113K | 0.01% | 517 |
|